EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)Open Access · CC BY-NC 3.0

Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects

Juan Wu iD, Hongrong Xu, Hui Li, Lei Ma, Juan Chen, Fei Yuan, Lei Sheng, Chao Liu iD, Weili Chen, Xuening Li iD

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s388846 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Juan Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology & Cancer Center, ZhongShan Hospital, Fudan University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Fasting, Protein Kinase Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FastingProtein Kinase InhibitorsHumansMaleHealthy VolunteersArea Under CurveBiological AvailabilityTherapeutic EquivalencyCross-Over StudiesFood-Drug InteractionsAdministration, OralTablets

Stichwörter der Autor:innen

SCC244c-Met inhibitorfood effectpharmacokineticssafety

Substanzen

Protein Kinase InhibitorsTablets

Autor:innen und Institutionen

  • Department of Clinical Pharmacology & Cancer Center, ZhongShan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Department of Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai JiaoTong University, Shanghai, People's Republic of China.
  • Haihe Biopharma Co., Ltd, Shanghai, People's Republic of China.

ORCID-Profile: Juan Wu, Chao Liu, Xuening Li

Zitieren

APA

Wu, J., Xu, H., Li, H., Ma, L., Chen, J., Yuan, F., Sheng, L., Liu, C., Chen, W., & Li, X. (2023). Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s388846

Vancouver

Wu J, Xu H, Li H, Ma L, Chen J, Yuan F, et al. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s388846

BibTeX
@article{Wu2023,
  author = {Wu, Juan and Xu, Hongrong and Li, Hui and Ma, Lei and Chen, Juan and Yuan, Fei and Sheng, Lei and Liu, Chao and Chen, Weili and Li, Xuening},
  title = {Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s388846}
}
Kostenlos starten →